PaxMedica announced that the management and Board of Directors of PaxMedica are aware of the recent market volatility in the company’s common stock. PaxMedica is not aware of any news that might be relevant to the recent share price fluctuations, however management takes its fiduciary responsibility very seriously, and have engaged the services of Shareholder Intelligence Services to better understand the investor base and the trading behavior around the company’s securities.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PXMD:
- PaxMedica Comments on Common Stock Volatility
- PaxMedica CEO Interviewed by The BRAIN Foundation
- PaxMedica submits clinical trial request in Autism Spectrum Disorder
- PaxMedica Enters Research Collaboration Agreement With PoloMar Health for Phase II Study in Autism Spectrum Disorder
- PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023
